Screening for Cervical Cancer: A Modeling Study for the U.S. Preventive Services Task Force

Por Kulasingam, Shalini L., Havrilesky, Laura J., Ghebre, Rahel, Myers, Evan R.
Publicado em 2013

Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Por Havrilesky, Laura J., Alvarez Secord, Angeles, Darcy, Kathleen M., Armstrong, Deborah K., Kulasingam, Shalini
Publicado em 2008

Robotic-Assisted Laparoscopic Gynecologic Procedures in a Fellowship Training Program

Por Lee, Paula S., Bland, Amy, Valea, Fidel A., Havrilesky, Laura J., Berchuck, Andrew, Secord, Angeles Alvarez
Publicado em 2009

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis

Por Davidson, Brittany A., Foote, Jonathan, Brower, Stacey L., Tian, Chunqiao, Havrilesky, Laura J., Secord, Angeles Alvarez
Publicado no Gynecol Oncol Res Pract (2016)

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment

Por Havrilesky, Laura J., Broadwater, Gloria, Davis, Debra M., Nolte, Kimberly C., Barnett, J. Cory, Myers, Evan R., Kulasingam, Shalini
Publicado em 2009

Comparison Of Methods To Estimate Health State Utilities For Ovarian Cancer Using Quality of Life Data: A Gynecologic Oncology Group Study

Por Hess, Lisa M., Brady, William E., Havrilesky, Laura J., Cohn, David E., Monk, Bradley J., Wenzel, Lari, Cella, David
Publicado em 2012

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Por Miller, Caela R., Chappell, Nicole P., Sledge, Caitlin, Leath, Charles A., Phippen, Neil T., Havrilesky, Laura J., Barnett, Jason C.
Publicado no Gynecol Oncol (2016)

Tumor grade and chemotherapy response in endometrioid endometrial cancer

Por Davidson, Brittany A., Foote, Jonathan, Clark, Leslie H., Broadwater, Gloria, Ehrisman, Jessie, Gehrig, Paola, Graybill, Whitney, Alvarez Secord, Angeles, Havrilesky, Laura J.
Publicado no Gynecol Oncol Rep (2016)

A cost-utility analysis of an NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected Quality-of-life scores in an economic model of treatment o...

Por Cohn, David E, Barnett, Jason C, Wenzel, Lari, Monk, Bradley J, Burger, Robert A, Straughn, J Michael, Myers, Evan R, Havrilesky, Laura J
Publicado no Gynecol Oncol (2014)

Performance of sentinel lymph node biopsy in high-risk endometrial cancer

Por Ehrisman, Jessie, Secord, Angeles Alvarez, Berchuck, Andrew, Lee, Paula S., Di Santo, Nicola, Lopez-Acevedo, Micael, Broadwater, Gloria, Valea, Fidel A., Havrilesky, Laura J.
Publicado no Gynecol Oncol Rep (2016)

A phase I trial of dasatinib, a Src-family kinase Inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer

Por Secord, Angeles Alvarez, Teoh, Deanna K., Barry, William T., Yu, Miao, Broadwater, Gloria, Havrilesky, Laura J., Lee, Paula S., Berchuck, Andrew, Lancaster, Johnathan, Wenham, Robert M.
Publicado em 2012

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer

Por Zhang, Chelsea, Roque, Dario, Ehrisman, Jessie A., DiSanto, Nicola, Broadwater, Gloria, Doll, Kemi M., Gehrig, Paola A., Secord, Angeles Alvarez, Havrilesky, Laura J.
Publicado no Gynecol Oncol Rep (2015)

Management of adnexal mass.

Por Myers, Evan R, Bastian, Lori A, Havrilesky, Laura J, Kulasingam, Shalini L, Terplan, Mishka S, Cline, Kathryn E, Gray, Rebecca N, McCrory, Douglas C
Publicado no Evid Rep Technol Assess (Full Rep) (2006)

Genomic tests for ovarian cancer detection and management.

Por Myers, Evan R, Havrilesky, Laura J, Kulasingam, Shalini L, Sanders, Gillian D, Cline, Kathryn E, Gray, Rebecca N, Berchuck, Andrew, McCrory, Douglas C
Publicado no Evid Rep Technol Assess (Full Rep) (2006)

TP53 Status is Associated with Thrombospondin1 Expression In vitro

Por Alvarez Secord, Angeles, Bernardini, Marcus Q., Broadwater, Gloria, Grace, Lisa A., Huang, Zhiqing, Baba, Tsukasa, Kondoh, Eiji, Sfakianos, Gregory, Havrilesky, Laura J., Murphy, Susan K.
Publicado em 2013

Disparities in the surgical staging of high-grade endometrial cancer in the United States

Por Foote, Jonathan R., Gaillard, Stephanie, Broadwater, Gloria, Sosa, Julie A., Davidson, Brittany, Adam, Mohamed A., Secord, Angeles Alvarez, Jones, Monica B., Chino, Junzo, Havrilesky, Laura J.
Publicado no Gynecol Oncol Res Pract (2017)

Patient preferences in advanced or recurrent ovarian cancer

Por Havrilesky, Laura J., Secord, Angeles Alvarez, Ehrisman, Jessie A., Berchuck, Andrew, Valea, Fidel A., Lee, Paula S., Gaillard, Stephanie, Samsa, Greg, Cella, David, Weinfurt, Kevin P., Abernethy, Amy P., Reed, Shelby D.
Publicado no Cancer (2014)

Patient and Physician Factors Associated with Participation in Cervical and Uterine Cancer Trials: An NRG/GOG247 Study

Por Brooks, Sandra E, Carter, Randy L, Plaxe, Steven C, Basen-Engquist, Karen M, Rodriguez, Michael, Kauderer, James, Walker, Joan L, Myers, Tashanna KN, Drake, Janet G, Havrilesky, Laura J, Van Le, Linda, Landrum, Lisa M., Brown, Carol L
Publicado no Gynecol Oncol (2015)

COMBINING MULTIPLE SERUM TUMOR MARKERS IMPROVES DETECTION OF STAGE I EPITHELIAL OVARIAN CANCER

Por Zhang, Zhen, Yu, Yinhua, Xu, Feng-Xi, Berchuck, Andrew, van Haaften-Day, Carolien, Havrilesky, Laura J., de Bruijn, Henk W. A., van der Zee, Ate G. J., Woolas, Robert P., Jacobs, Ian J., Skates, Steven, Chan, Daniel W., Bast, Robert C.
Publicado em 2007

Oral contraceptive use for the primary prevention of ovarian cancer.

Por Havrilesky, Laura J, Gierisch, Jennifer M, Moorman, Patricia G, Coeytaux, Remy R, Urrutia, Rachel Peragallo, Lowery, William J, Dinan, Michaela, McBroom, Amanda J, Wing, Liz, Musty, Michael D, Lallinger, Kathryn R, Hasselblad, Vic, Sanders, Gillian D, Myers, Evan R
Publicado no Evid Rep Technol Assess (Full Rep) (2013)